Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.52 AUD | +2.37% | +0.26% | -3.56% |
Apr. 29 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bearish |
Resistance | 16.18 | 18.09 | 16.83 |
Spread/Res. | -4.64% | -14.70% | -8.32% |
Spread/Supp. | +8.28% | +16.89% | +15.67% |
Support | 14.25 | 13.20 | 13.34 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CUV Stock
- Charts Clinuvel Pharmaceuticals Limited